Literature DB >> 29439350

Early Tau Burden Correlates with Higher Rate of Atrophy in Transentorhinal Cortex.

Long Xie1,2, Sandhitsu R Das1,3,4, Laura E M Wisse1,4, Ranjit Ittyerah1,4, Paul A Yushkevich1,4, David A Wolk5,3.   

Abstract

Neurofibrillary tangle (NFT) pathology is linked to neurodegeneration in the medial temporal lobe (MTL). Using a tailored pipeline, we correlated atrophy rate, as measured from retrospective longitudinal MRI, with NFT burden, measured from 18F-AV-1451 PET, within MTL regions of earliest NFT pathology. In amyloid-β positive but not amyloid-β negative individuals, we found significant correlation between 18F-AV-1451 uptake and atrophy rate that was strongest in the transentorhinal cortex, the first region with NFT pathology. This supports the role of NFTs in driving neurodegeneration and the utility of 18F-AV-1451 PET and structural measurement of transentorhinal cortex in tracking early tau-mediated disease progression.

Entities:  

Keywords:  18F-AV-1451 PET; Alzheimer’s disease; amyloid; medial temporal lobe; structural atrophy

Mesh：

Substances：

Year:  2018        PMID： 29439350      PMCID： PMC5880816          DOI： 10.3233/JAD-170945

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN： 1387-2877            Impact factor:   4.472


  21 in total

1.  Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI.

Authors:  Sandhitsu R Das; Brian B Avants; John Pluta; Hongzhi Wang; Jung W Suh; Michael W Weiner; Susanne G Mueller; Paul A Yushkevich
Journal:  Neuroimage       Date:  2012-01-28       Impact factor: 6.556

2.  Cognitive decline associated with pathological burden in primary age-related tauopathy.

Authors:  Kyra S Jefferson-George; David A Wolk; Edward B Lee; Corey T McMillan
Journal:  Alzheimers Dement       Date:  2017-03-16       Impact factor: 21.566

3.  [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.

Authors:  Chun-Fang Xia; Janna Arteaga; Gang Chen; Umesh Gangadharmath; Luis F Gomez; Dhanalakshmi Kasi; Chung Lam; Qianwa Liang; Changhui Liu; Vani P Mocharla; Fanrong Mu; Anjana Sinha; Helen Su; A Katrin Szardenings; Joseph C Walsh; Eric Wang; Chul Yu; Wei Zhang; Tieming Zhao; Hartmuth C Kolb
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

4.  In Vivo Tau, Amyloid, and Gray Matter Profiles in the Aging Brain.

Authors:  Jorge Sepulcre; Aaron P Schultz; Mert Sabuncu; Teresa Gomez-Isla; Jasmeer Chhatwal; Alex Becker; Reisa Sperling; Keith A Johnson
Journal:  J Neurosci       Date:  2016-07-13       Impact factor: 6.167

5.  Accounting for the Confound of Meninges in Segmenting Entorhinal and Perirhinal Cortices in T1-Weighted MRI.

Authors:  Long Xie; Laura E M Wisse; Sandhitsu R Das; Hongzhi Wang; David A Wolk; Jose V Manjón; Paul A Yushkevich
Journal:  Med Image Comput Comput Assist Interv       Date:  2016-10-02

6.  Multi-template analysis of human perirhinal cortex in brain MRI: Explicitly accounting for anatomical variability.

Authors:  Long Xie; John B Pluta; Sandhitsu R Das; Laura E M Wisse; Hongzhi Wang; Lauren Mancuso; Dasha Kliot; Brian B Avants; Song-Lin Ding; José V Manjón; David A Wolk; Paul A Yushkevich
Journal:  Neuroimage       Date:  2016-10-01       Impact factor: 6.556

Review 7.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

8.  The association between tau PET and retrospective cortical thinning in clinically normal elderly.

Authors:  Molly R LaPoint; Jasmeer P Chhatwal; Jorge Sepulcre; Keith A Johnson; Reisa A Sperling; Aaron P Schultz
Journal:  Neuroimage       Date:  2017-05-22       Impact factor: 6.556

9.  In vivo Patterns of Tau Pathology, Amyloid-β Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease.

Authors:  Julian Dronse; Klaus Fliessbach; Gérard N Bischof; Boris von Reutern; Jennifer Faber; Jochen Hammes; Georg Kuhnert; Bernd Neumaier; Oezguer A Onur; Juraj Kukolja; Thilo van Eimeren; Frank Jessen; Gereon R Fink; Thomas Klockgether; Alexander Drzezga
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

10.  An autoradiographic evaluation of AV-1451 Tau PET in dementia.

Authors:  Val J Lowe; Geoffry Curran; Ping Fang; Amanda M Liesinger; Keith A Josephs; Joseph E Parisi; Kejal Kantarci; Bradley F Boeve; Mukesh K Pandey; Tyler Bruinsma; David S Knopman; David T Jones; Leonard Petrucelli; Casey N Cook; Neill R Graff-Radford; Dennis W Dickson; Ronald C Petersen; Clifford R Jack; Melissa E Murray
Journal:  Acta Neuropathol Commun       Date:  2016-06-13       Impact factor: 7.801
View more
  14 in total

1.  Alzheimer's pathology targets distinct memory networks in the ageing brain.

Authors:  Anne Maass; David Berron; Theresa M Harrison; Jenna N Adams; Renaud La Joie; Suzanne Baker; Taylor Mellinger; Rachel K Bell; Kaitlin Swinnerton; Ben Inglis; Gil D Rabinovici; Emrah Düzel; William J Jagust
Journal:  Brain       Date:  2019-08-01       Impact factor: 13.501

2.  Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.

Authors:  Christopher Gonzalez; Nicole S Tommasi; Danielle Briggs; Michael J Properzi; Rebecca E Amariglio; Gad A Marshall
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 3.  Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer's disease and supporting differential diagnosis.

Authors:  Wenyan Zhang; Shuoyan Xu; Hongmei Yu; Xuena Li; Zhuangzhuang Jin; Yaming Li; Zhiyi He
Journal:  Ann Nucl Med       Date:  2021-01-18       Impact factor: 2.668

4.  Medial Temporal Lobe Networks in Alzheimer's Disease: Structural and Molecular Vulnerabilities.

Authors:  Robin de Flores; Sandhitsu R Das; Long Xie; Laura E M Wisse; Xueying Lyu; Preya Shah; Paul A Yushkevich; David A Wolk
Journal:  J Neurosci       Date:  2022-01-27       Impact factor: 6.709

5.  In vivo measures of tau burden are associated with atrophy in early Braak stage medial temporal lobe regions in amyloid-negative individuals.

Authors:  Sandhitsu R Das; Long Xie; Laura E M Wisse; Nicolas Vergnet; Ranjit Ittyerah; Salena Cui; Paul A Yushkevich; David A Wolk
Journal:  Alzheimers Dement       Date:  2019-09-06       Impact factor: 21.566

6.  Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease.

Authors:  Robin de Flores; Laura E M Wisse; Sandhitsu R Das; Long Xie; Corey T McMillan; John Q Trojanowski; John L Robinson; Murray Grossman; Edward Lee; David J Irwin; Paul A Yushkevich; David A Wolk
Journal:  Alzheimers Dement       Date:  2020-04-22       Impact factor: 21.566

Review 7.  Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease.

Authors:  Dallas P Veitch; Michael W Weiner; Paul S Aisen; Laurel A Beckett; Charles DeCarli; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Susan M Landau; John C Morris; Ozioma Okonkwo; Richard J Perrin; Ronald C Petersen; Monica Rivera-Mindt; Andrew J Saykin; Leslie M Shaw; Arthur W Toga; Duygu Tosun; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2021-09-28       Impact factor: 16.655

8.  Downstream effects of polypathology on neurodegeneration of medial temporal lobe subregions.

Authors:  L E M Wisse; S Ravikumar; R Ittyerah; S Lim; J Lane; M L Bedard; L Xie; S R Das; T Schuck; M Grossman; E B Lee; M D Tisdall; K Prabhakaran; J A Detre; G Mizsei; J Q Trojanowski; E Artacho-Pérula; M M de Iñiguez de Onzono Martin; M M Arroyo-Jiménez; M Muñoz Lopez; F J Molina Romero; M P Marcos Rabal; S Cebada Sánchez; J C Delgado González; C de la Rosa Prieto; M Córcoles Parada; D A Wolk; D J Irwin; R Insausti; P A Yushkevich
Journal:  Acta Neuropathol Commun       Date:  2021-07-21       Impact factor: 7.801

9.  Affective symptoms and regional cerebral tau burden in early-stage Alzheimer's disease.

Authors:  Nicole S Tommasi; Christopher Gonzalez; Danielle Briggs; Michael J Properzi; Jennifer R Gatchel; Gad A Marshall
Journal:  Int J Geriatr Psychiatry       Date:  2021-03-15       Impact factor: 3.850

10.  Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.

Authors:  Omar A Halawa; Jennifer R Gatchel; Rebecca E Amariglio; Dorene M Rentz; Reisa A Sperling; Keith A Johnson; Gad A Marshall
Journal:  Alzheimers Res Ther       Date:  2019-01-31       Impact factor: 6.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.